Prozymi Biolabs

Prozymi Biolabs is a biotechnology company that has developed an innovative enzyme-based technology to produce gluten-safe bread and baked goods. By identifying and utilizing naturally derived enzymes that selectively degrade gliadin—the immunogenic protein fragment responsible for gluten-related health conditions—the company enables the production of wheat-based products that are safe for individuals with coeliac disease or gluten sensitivity. This process preserves the remaining gluten structure, allowing for the retention of the traditional taste, texture, and nutritional profile typically lost in conventional gluten-free products made from alternative flours like rice or tapioca.

This technology addresses significant gaps in the current gluten-free market by offering a superior, more nutritious, and affordable alternative to existing products. The company’s approach is designed to simplify production for manufacturers while providing a better experience for consumers. Since its founding in 2021, Prozymi Biolabs has engaged in numerous research collaborations with UK-based academic institutions and has participated in various startup incubators and innovation programs to advance its proof-of-concept, optimize enzyme expression systems, and refine its application in real-world dough preparation workflows.